Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study
The relevance of circulating tumor DNA (ctDNA) analysis as a liquid biopsy and minimal residual disease tool in the management of classical Hodgkin Lymphoma (cHL) patients was demonstrated in retrospective settings and remains to be confirmed in a Compression Tops prospective setting.We developed a targeted Next-Generation sequencing (NGS) panel fo